The cost of rheumatoid arthritis

British Journal of Rheumatology

Volumn 35, Issue 8, 1996, Pages 781-790

  McIntosh, E ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Cost of illness; Direct costs; Economic impact; Indirect costs; Rheumatoid arthritis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; FEMALE; HEALTH CARE COST; HUMAN; MALE; PHYSICAL DISABILITY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SOCIETY; UNITED KINGDOM;

EID: 0029782501     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/35.8.781     Document Type: Article

References (33)

1. Hu T, Sandifer FH (1981) Synthesis of Cost of Illness methodology: National Center for Health Services Research. contract no. 233-79-3010, Washington, Georgetown University. In: Rice D, Hodgson T, Kopstein, A., eds. The economic costs of illness: a replication and update. Health Care Financ Rev 1985;7:61-80.
2. Rice DP, Hodgson T, Kopstein A. The economic costs of illness: a replication and update. Health Care Financ Rev 1985;7:61-80.
3. Drummond MF. Cost of illness studies - a major headache? Pharmacoeconomics 1992;2:1-4.
4. Rice DP. Estimating the cost of illness. US Department Health Education and Welfare, Health Economics Series no. 6 (Microfilm), 1966.
5. Liang MH, Katz JN. Measurement of outcome in rheumatoid arthritis. Baillière's Clin Rheumatol 1992;6:23-37.
6. Jonsson B, Bebbington PE. What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. Br J Psychiatry 1994;164:665-73.
7. HMSO. Morbidity statistics from general practice, 3rd national study 1981-1982. London: HMSO, 1986.
8. Office of Population Censuses and Surveys Social Survey Division Survey of Disabled Adults in Private Households, 1985 [computer file]. Colchester: ESRC Data Archive, 1989.
9. Office of Population Censuses and Surveys Social Survey Division Survey of Disability Among Adults in Communal Establishments, 1986 [computer file]. Colchester: ESRC Data Archive, 1989.
10. Goldberg D, Huxley P. Common mental disorders: a bio-social model. London: Routledge, 1992.
11. Kavanagh S, Forder J, Opit L. The cost of depression in England, discussion paper 902. Canterbury: Personal Social Services Research Unit, University of Kent at Canterbury, 1993.
12. Netten A. Unit costs of community care 1994. Canterbury: Personal Social Services Research Unit, University of Kent at Canterbury, 1994.
13. Chartered Institute of Public Finance Accountancy. Health database 1991. London: CIPFA, 1992.
14. Beecham J. Costing services: an update, discussion paper 844. Canterbury: Personal Social Services Research Unit, University of Kent at Canterbury, 1992.
15. Monthly index of medical specialties (MIMS) November 1992. London: Haymarket Medical Ltd, 1992.
16. Reisine S, Grady K, Goodenow C, Fifeld J. Work disability among women with rheumatoid arthritis: the relative importance of disease, social, work and family factors. Arthritis Rheum 1989;32:539-43.
17. Yelin E, Henke C, Epstein W. The work dynamics of the person with rheumatoid arthritis. Arthritis Rheum 1987;30:507-12.
18. Pincus T, Callahan LF, Brooks RH et al. Self-report questionnaire scores in rheumatoid arthritis compared with traditional physical, radiographic and laboratory measures. Ann Intern Med 1989;110:259-66.
19. Wyles M. Arthritis. London: Office of Health Economics, 1992.
20. Lawrence JS. Prevalence of rheumatoid arthritis. Ann Rheum Dis 1961;20:11-7.
21. Lubeck DP, Spitz PW, Fries JF et al. A multicenter study of annual health service utilisation and costs of rheumatoid arthritis. Arthritis Rheum 1986;29:488-93.
22. Wolfe F, Pincus T (eds) Rheumatoid arthritis: pathogenesis, assessment, outcome and treatment. New York: Marcel Dekker Inc., 1994.
23. Meenan R, Yelin E, Henke C et al. The costs of rheumatoid arthritis: a patient oriented study of chronic disease costs. Arthritis Rheum 1978;21:827-33.
24. Jacobs J, Keyserling JA, Britton M, Morgan GJ Jr, Wilkenfield J, Hutchings HC. The total cost of care and the use of pharmaceuticals in the management of rheumatoid arthritis: the medical program. J Clin Epidemiol 1988;41:215-33.
25. Thompson MS, Read JL, Hutching HC, Paterson M, Harris ED. The cost effectiveness of auranofin: the results of a randomised clinical trial. J Rheumatol 1988;15:35-42.
26. Liang M, Larson M, Thompson M et al. Costs and outcomes in rheumatoid and osteoarthritis. Arthritis Rheum 1984;27:522-9. In: Wolfe F, Pincus T, eds. Rheumatoid arthritis: pathogenesis, assessment, outcome and treatment. New York: Marcel Dekker Inc., 1994.
27. Liang M, Larson M, Thompson M et al. Costs and outcomes in rheumatoid and osteoarthritis. Arthritis Rheum 1984;27:522-9. In: Wolfe F, Pincus T, eds. Rheumatoid arthritis: pathogenesis, assessment, outcome and treatment. New York: Marcel Dekker Inc., 1994.
28. Stone C. The lifetime costs of rheumatoid arthritis. J Rheumatol 1984;11:819-27.
29. Davies L, Drummond MF. The economic burden of schizophrenia. Psychiatric Bull 1990;14:522-5.
30. Gray A, Fenn P. Alzheimer's disease: the burden of illness in England. Health Trends 1993;25:31-7.
31. Shiell A, Gerard K, Donaldson C. Cost of Illness: an aid to decision making? Health Policy 1987;8:317-23.
32. Hodgson TA. Cost of Illness: no aid to decision making? Comments on the second opinion by Shiell et al. (Health Policy 1987;8:317-23). Health Policy 1989;11:57-60.
33. Hodgson TA. Cost of Illness: no aid to decision making? Comments on the second opinion by Shiell et al. (Health Policy 1987;8:317-23). Health Policy 1989;11:57-60.